Invivyd Inc
Invivyd Inc, formerly known as Adagio Therapeutics, is a biotechnology company developing therapeutic solutions for the management of infectious diseases.
Price history of Invivyd Inc
Price history of Invivyd Inc
Performance & Momentum
Invivyd Reports Strong Q4 Growth, Launches COVID Antibody Phase 3
Invivyd announced preliminary product revenue of $17.2M for Q4 2025, up 25% year-over-year and 31% from the prior quarter, driven by its drug PEMGARDA. The company also initiated Phase 3 trials for VYD2311, an alternative COVID antibody to vaccines, with results expected by mid-2026. This trial benefits from Fast Track designation. Coupled with a strong $227M cash position, these clinical and financial strengths boost outlooks and have resulted in positive analyst consensus, targeting $10 per share.
Strategic Analysis
Invivyd Inc • 2026
Invivyd Inc positions itself as a biotechnology company focused on preventing infectious diseases through antibodies and prophylactic approaches. Its differentiation lies in a highly targeted niche at the intersection of immunology and viral infection control, with a specialized-solution approach rather than a broad portfolio strategy.
- Expertise in a defensive and scientifically differentiated niche in infectious diseases
- Positioning in antibodies and prophylactic therapies, a segment with strong medical potential if clinical evidence follows
- Significant rerating potential in the event of regulatory or clinical success
- Typical speculative profile of a small biotech, with heavy dependence on clinical and regulatory milestones
- Fragile market history, indicating limited investor confidence and execution perceived as uncertain
Momentum appears strong in the near term, with a visible rebound after a sharp recent de-rating. However, the trend remains fragile, as it comes against a backdrop of very high volatility and a long-term performance record that has deteriorated. For investors, this points more to a speculative rebound play than to a firmly established underlying trend.
Similar stocks to Invivyd Inc
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
